Richard Buchholz - 25 Jan 2023 Form 4 Insider Report for Inspire Medical Systems, Inc. (INSP)

Role
Chief Financial Officer
Signature
/s/ Bryan Phillips, Attorney-in-Fact for Richard Buchholz
Issuer symbol
INSP
Transactions as of
25 Jan 2023
Net transactions value
+$155,967
Form type
4
Filing time
27 Jan 2023, 19:00:36 UTC
Previous filing
13 Jan 2023
Next filing
14 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INSP Common Stock Options Exercise $34,150 +3,290 +9.6% $10.38* 37,677 25 Jan 2023 Direct
transaction INSP Common Stock Options Exercise $8,307 +117 +0.31% $71.00 37,794 25 Jan 2023 Direct
transaction INSP Common Stock Options Exercise $113,510 +2,693 +7.1% $42.15* 40,487 25 Jan 2023 Direct
holding INSP Common Stock 1,225 25 Jan 2023 By Daughter
holding INSP Common Stock 1,225 25 Jan 2023 By Son
holding INSP Common Stock 1,225 25 Jan 2023 By Son
holding INSP Common Stock 1,225 25 Jan 2023 By Son

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INSP Employee Stock Option (Right to Buy) Options Exercise $0 -3,290 -100% $0.000000* 0 25 Jan 2023 Common Stock 3,290 $10.38 Direct F1
transaction INSP Employee Stock Option (Right to Buy) Options Exercise $0 -117 -0.65% $0.000000 17,849 25 Jan 2023 Common Stock 117 $71.00 Direct F2
transaction INSP Employee Stock Option (Right to Buy) Options Exercise $0 -2,693 -27% $0.000000 7,159 25 Jan 2023 Common Stock 2,693 $42.15 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is fully vested and exercisable.
F2 The option vested and became exercisable as to 25% of the original 20,000 underlying shares on December 16, 2020 and has vested or will vest and become exercisable with respect to the remaining 75% of the original underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.